PMA device
Medtronic(R) Transvene Lead System
Medtronic, Inc. · Permanent Defibrillator Electrodes (NVY, Class III) · First FDA decision Aug 24, 2016, newest Apr 23, 2020Ventricular arrhythmia and sudden cardiac arrest
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
0
Naming "Medtronic Transvene"
MAUDE reports
0
Brand "Medtronic Transvene", since 2015
PubMed studies
10
Mentioning "Medtronic Transvene"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Medtronic(R) Transvene Lead System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- MEDTRONIC(R) TRANSVENE LEAD SYSTEMPMA supplement
P920015-S234 · Decided Apr 23, 2020 · 297 days after receipt · Normal 180 Day Track
Device type: Permanent defibrillator electrodes (NVY) · Cardiology
- MEDTRONIC(R) TRANSVENE LEAD SYSTEMPMA supplement
P920015-S175 · Decided Aug 24, 2016 · 176 days after receipt · Normal 180 Day Track
Device type: Permanent defibrillator electrodes (NVY) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Medtronic Transvene", any status and sponsor, newest update first.
No registered device study names "Medtronic Transvene".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Medtronic Transvene", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NVY
107,231 reports: 45,328 malfunction, 59,528 injury, 2,263 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Medical Device Identification Cards associated with Sprint Quattro Lead, Product/CFN 6935M72Terminated
Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
Z-0390-2022 · Started Nov 8, 2021
Reason given: The back of some Medical Device Identification Cards provided to patients were printed with an erroneous statement stating the following: "This patient has a complete MR conditional system implanted."
Cause as FDA categorized it: Error in labeling · Device type: Permanent Defibrillator Electrodes (NVY)
- Medical Device Identification Cards associated with Astra XT DR Implantable pulse generatorTerminated
Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
Z-0391-2022 · Started Nov 8, 2021
Reason given: The back of some Medical Device Identification Cards provided to patients were printed with an erroneous statement stating the following: "This patient has a complete MR conditional system implanted."
Cause as FDA categorized it: Error in labeling · Device type: Pulse Generator, Permanent, Implantable (NVZ)
Medtronic Inc. Cardiac Rhythm Managment
Z-0067-2008 · Started Oct 15, 2007 · Posted by FDA Oct 25, 2007
Reason given: Medtronic Cardiac Rhythm Disease Management has voluntarily suspended worldwide distribution of the Sprint Fidelis family of defibrillation leads because of the potential for lead fractures. In addition, the company recommends against new implants of the leads (Sprint Fidelis Models: 6930, 6931, 6948, 6949)....
Cause as FDA categorized it: Device Design · Device type: Implantable Cardioverter Defibrillator (Non-Crt) (LWS)
3 more recall records with a free account
Published research
The most relevant PubMed records for "Medtronic Transvene"[tiab]. The summary above synthesizes these.
- Recording of pacing stimulus artifacts by endovascular defibrillation lead systems: comparison of true and integrated bipolar circuits.
Menz V, Schwartzman D, Drachman D, et al. · J Interv Card Electrophysiol · 1998Comparative Study, Research Support, Non-U.S. Gov't
- Effects of high and low shock energies on sinus electrograms recorded via integrated and true bipolar nonthoracotomy lead systems.
Gottlieb CD, Schwartzman DS, Callans DJ, et al. · J Cardiovasc Electrophysiol · 1996Comparative Study, Research Support, Non-U.S. Gov't
- Relative efficacy of different tilts with biphasic defibrillation in humans.
Natale A, Sra J, Krum D, et al. · Pacing Clin Electrophysiol · 1996Clinical Trial, Comparative Study
- Reproducibility of ventricular fibrillation characteristics in patients undergoing implantable cardioverter defibrillator implantation.
Taneja T, Goldberger J, Parker MA, et al. · J Cardiovasc Electrophysiol · 1997Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- Preliminary experience with nonthoracotomy implantable cardioverter defibrillators in young patients. The Medtronic Transvene Investigators.
Kron J, Silka MJ, Ohm OJ, et al. · Pacing Clin Electrophysiol · 1994
- Surgical experience with defibrillator implantation using nonthoracotomy leads.
Hammel D, Block M, Konertz W, et al. · Ann Thorac Surg · 1993
- Lead fracture in cephalic versus subclavian approach with transvenous implantable cardioverter defibrillator systems.
Gallik DM, Ben-Zur UM, Gross JN, et al. · Pacing Clin Electrophysiol · 1996Comparative Study
- Late complications in patients with pectoral defibrillator implants with transvenous defibrillator lead systems: high incidence of insulation breakdown.
Mehta D, Nayak HM, Singson M, et al. · Pacing Clin Electrophysiol · 1998
- Acute efficacy and chronic follow-up of patients with non-thoracotomy third generation implantable defibrillators.
Brachmann J, Sterns LD, Hilbel T, et al. · Pacing Clin Electrophysiol · 1994
- Early postoperative rise in defibrillation threshold in patients with nonthoracotomy defibrillation lead systems: attenuation with biphasic shock waveforms.
Schwartzman D, Callans DJ, Gottlieb CD, et al. · J Cardiovasc Electrophysiol · 1996Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code NVY.
- Sprint Quattro Secure MRI SureScan Model 6947M leadMedtronic, Inc. · PMA 2022
- Attain Starfix LeadMedtronic, Inc. · PMA 2014
- Capsurefix Novus MRI Surescan Lead Model 5076Medtronic, Inc. · PMA 2016
- Passive Plus, Isoflex S&p, and Isoflex Optim LeadsAbbott Medical · PMA 2015
- OmniaSecure MRI SureScan Lead Model 3930MMedtronic, Inc. · PMA 2026
- Selectsecure LeadMedtronic Cardiac Rhythm Disease Management · PMA 2016
- Medtronic 4195 Attain Starfix Model 4195 LV LeadMedtronic, Inc. · PMA 2014
- Capsure Epicardial Pacing LeadMedtronic, Inc. · PMA 2013
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.